Target intelligence / Profile preview

HIV-1 reverse transcriptase ribonuclease H domain (HIV-1 RT RNase H)

Target
HIV-1 RT RNase H
Molecular classification
Enzyme, Ribonuclease, Hydrolase, Retroviral enzyme domain
01

Overview

HIV-1 reverse transcriptase ribonuclease H domain is a specialized enzyme domain located at the C-terminus of the p66 subunit in the HIV-1 reverse transcriptase heterodimer. The enzyme has two critical, spatially separated activities: DNA polymerase (which copies viral RNA into DNA) and RNase H (which degrades the RNA strand of RNA/DNA hybrids during reverse transcription)[1][3][4]. The RNase H domain is essential for proper processing and removal of RNA primers, ensuring successful synthesis and integration of the viral DNA into the host genome[1][4]. RNase H function is required for HIV infectivity, making it an established and validated antiviral drug target. While the majority of HIV therapies target the RT polymerase, RNase H remains of interest for novel inhibitor development and overcoming drug resistance[1][2][4].

Other names
HIV-1 RNase HHIV-1 reverse transcriptase RNase H domainRNase H of HIV-1 reverse transcriptase
02

Mechanism of action

Inhibition of RNA cleavage in RNA/DNA hybrids, thus blocking conversion of viral RNA into DNA and interfering with viral replication. Blockade of reverse transcription, which prevents HIV-1 from integrating into host DNA[1][2].

03

Biological functions

Reverse transcriptionRNA degradationtRNA primer removalPrimer definition for viral DNA synthesis
04

Disease associations

Infection
05

Safety considerations

Resistance developmentPotential off-target effectsTherapeutic window limitations
06

Interacting drugs

Nucleoside reverse transcriptase inhibitors (NRTIs)

2 more in the full profile.

Beyond the preview

Go deeper on HIV-1 reverse transcriptase ribonuclease H domain (HIV-1 RT RNase H).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 reverse transcriptase ribonuclease H domain (HIV-1 RT RNase H).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call